US Drug Recall Register
Class III · Low risk Terminated Initiated Oct 20, 2015 (11 years ago)

Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect or Missing Lot AND/OR Exp Date.

What was recalled

Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98

Recalling firm
Teva Pharmaceutical Industries
NDC code
0093-8238-98
Origin
N/A, Israel
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0521-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Hydrochlorothiazide recalls

See all